Clinical Trial Update: Total Antioxidant Effects of Esomeprazole in Dyspeptic Patients Receiving Non-steroidal Anti-inflammatory Drugs [Phase 4]

View source ↗

Summary

Clinical trial investigating total antioxidant effects of esomeprazole in dyspeptic patients on NSAIDs was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Dyspepsia | Phase 4 | Status: WITHDRAWN